Mycoplasma gallisepticum formulation

Details Mycoplasma gallisepticum formulation Mycoplasma gallisepticum formulation

C - Chemistry, Metallurgy

12

N

C12N 1/20 (2006.01) A61K 39/02 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2749213

The present invention provides a formulation that prevents virulent Mycoplasma galHsepticum infection in birds of the order GaIHf ormes. The formulation comprises live Mycoplasma galHsepticum strain K5831 or derivatives thereof in a pharmaceutically acceptable carrier. A vaccine that prevents virulent Mycoplasma galHsepticum infection in birds of the order Galliformes is also presented. Methods for administering the formulation and vaccine are also presented.

La présente invention concerne une composition prévenant les infections virulentes à Mycoplasma gallisepticum chez les oiseaux de l'ordre des Galliformes. Cette composition contient des mycoplasmes (souche K5831 de Mycoplasma gallisepticum) vivants ou des dérivés de ceux-ci dans un excipient pharmaceutiquement acceptable. L'invention concerne également un vaccin prévenant les infections virulentes à Mycoplasma gallisepticum chez les oiseaux de l'ordre des Galliformes, ainsi que des procédés d'administration de ladite composition et dudit vaccin.

Affiliated with

Also associated with

Rating

Mycoplasma gallisepticum formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mycoplasma gallisepticum formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycoplasma gallisepticum formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1870584